Biotalys, Ackermans & van Haaren unit, posts H1 net loss of €9.14 million

Reuters2026/08/20 05:19

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Biotalys, a subsidiary of Ackermans & van Haaren, posted a net loss of EUR 9.14 million in H1 2026, versus EUR 8.14 million.
Normalized net loss improved to EUR 7.2 million from EUR 8.14 million, reflecting restructuring costs of EUR 1.94 million.
Cash totaled EUR 11.93 million at June 30, 2026, implying runway through end-Q1 2027.
Operating cash outflow rose to EUR 7.61 million from EUR 6.09 million, driven by restructuring-related payments.
Private placement raised EUR 12.05 million; operations refocused on EVOCA NG and BioFun-6 to curb cash burn.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ackermans & van Haaren NV published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Biotalys, Ackermans & van Haaren unit, posts H1 net loss of €9.14 million

You may also like

Crypto prices